We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Molecular Imaging Using Radiolabeled Atezolizumab to Assess Atezolizumab Biodistribution in Lymphoma Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03850028
Recruitment Status : Recruiting
First Posted : February 21, 2019
Last Update Posted : June 18, 2019
Amsterdam UMC, location VUmc
Stichting Hemato-Oncologie voor Volwassenen Nederland
Hoffmann-La Roche
Information provided by (Responsible Party):
Marcel Nijland, University Medical Center Groningen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 2, 2025
Estimated Study Completion Date : April 2, 2025